St. John's Wort: more implications for cancer patients.

@article{Mansky2002StJW,
  title={St. John's Wort: more implications for cancer patients.},
  author={P. Mansky and S. Straus},
  journal={Journal of the National Cancer Institute},
  year={2002},
  volume={94 16},
  pages={
          1187-8
        }
}
  • P. Mansky, S. Straus
  • Published 2002
  • Biology, Medicine
  • Journal of the National Cancer Institute
  • St. John’s wort (Hypericum perforatum L.) has been used as a medicinal plant in Europe and Asia for centuries. Although it is best known today for its use by patients with mild to moderately severe depression, St. John’s wort has also been used orally as a traditional treatment for excitability, neuralgia, fibrositis, sciatica, and anxiety and as a topical preparation for the treatment of wounds (1). Concerns over its use have been raised with the recognition that, whatever its beneficial… CONTINUE READING
    26 Citations

    Paper Mentions

    Herbal remedies in the United States: potential adverse interactions with anticancer agents.
    • 309
    Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review
    • 87
    Drug Interactions and the Pharmacist: Focus on Everolimus
    • 13
    Unconventional therapy for prostate cancer: good, bad or questionable?
    • 53
    • PDF
    Hyperforin Inhibits Cancer Invasion and Metastasis
    • 122
    • PDF

    References

    SHOWING 1-10 OF 18 REFERENCES
    Effects of St. John's wort on irinotecan metabolism.
    • 395
    • PDF
    St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.
    • 853
    • PDF
    St Johns wort increases expression of P-glycoprotein: implications for drug interactions.
    • 258
    St John's Wort induces intestinal P‐glycoprotein/MDR1 and intestinal and hepatic CYP3A4
    • 564
    Different effects of St John's Wort on the pharmacokinetics of simvastatin and pravastatin
    • 221
    Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.
    • 980